Joey CohenMedication Adherence
Amy GilesIncreasing Engagement
Pat PurcellMeeting Engagement
Suma Ramadas, PhDMedical Affairs
Frank BurrellScientific Storytelling
Matthew DurhamOmnidynamic Marketing
Daniel SontupeMarket Access
Stacey GandlerBrand Nourishment
Bud BilanichSuccess Coach
Paul TheisenPatient Acquisition
Liz KaneImpactful Strategy
David LinetskyPoint-of-Care Marketing
Brenda SnowAuthentic Patient Voice
Matt TurnerPatient Affordability
YELIVA®, a proprietary, first-in-class SK2 inhibitor, was granted FDA Orphan Drug designation for the ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email